Received Apr 9, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | UNK | LA |
she noticed tingling and numbness in her fingertips on both arms; she noticed tingling and numbness in her fingertips on both arms; This non-serious case was reported by a consumer via call center representative and described the occurrence of tingling of extremity in a 54-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis. On 07-MAR-2025, the patient received the 2nd dose of Shingrix (left arm). In MAR-2025, less than 2 weeks after receiving Shingrix, the patient experienced tingling of extremity (Verbatim: she noticed tingling and numbness in her fingertips on both arms) and numbness of upper arm (Verbatim: she noticed tingling and numbness in her fingertips on both arms). The outcome of the tingling of extremity and numbness of upper arm were unknown. It was unknown if the reporter considered the tingling of extremity and numbness of upper arm to be related to Shingrix. It was unknown if the company considered the tingling of extremity and numbness of upper arm to be related to Shingrix. Additional Information: GSK Receipt Date: 19-MAR-2025: Reporter was the patient who states that she received her second dose of Shingrix on 7 March 2025 on her left arm. This past week, she noticed tingling and numbness in her fingertips on both arms.